DAB2IP is often lost in the early stages of tumor development, resulting in the production of inflammatory mediators and an enrichment of macrophages, suggesting a potential role for DAB2IP in remodeling the tumor immune microenvironment [9]. Here, DAB2IP is linked to neoplasm.